Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2058724 | MethodsX | 2014 | 7 Pages |
Rebamipide is a mucoprotective agent commonly used to prevent nonsteriodal anti-inflammatory drug-induced gastrointenstinal side effects [1]. Human plasma and urine analysis of rebamipide utilizing high performance liquid chromatography (HPLC) have been reported [2]. Recently, we reported on the plasma levels of rebamipide in presense or absence of celecoxib or diclofenac in rats [3] using a modified HPLC method of detection developed by Jeoung et al. [4]. To tailor the method towards use in urinary rebamipide extraction and analysis, the following modifications were made:•To compensate for high concentrations of rebamipide found in urine, a new rebamipide stock solution was prepared with a final concentration of 50,000 ng/mL.•Rat urine calibration standards were obtained within the range of 50–1000 ng/mL and 1000–50,000 ng/mL.•Plasma samples were replaced with urine samples.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide